高级搜索

不同治疗模式对ⅡB期宫颈癌患者预后和生活质量的影响

阳志军, 陈艳丽, 李力, 姚德生, 张洁清

阳志军, 陈艳丽, 李力, 姚德生, 张洁清. 不同治疗模式对ⅡB期宫颈癌患者预后和生活质量的影响[J]. 肿瘤防治研究, 2014, 41(09): 1021-1025. DOI: 10.3971/j.issn.1000-8578.2014.09.014
引用本文: 阳志军, 陈艳丽, 李力, 姚德生, 张洁清. 不同治疗模式对ⅡB期宫颈癌患者预后和生活质量的影响[J]. 肿瘤防治研究, 2014, 41(09): 1021-1025. DOI: 10.3971/j.issn.1000-8578.2014.09.014
YANG Zhijun, CHEN Yanli, LI Li, YAO Desheng, ZHANG Jieqing. Impact of Different Treatment Models on Prognosis and QOL of Patients with Stage ⅡB Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(09): 1021-1025. DOI: 10.3971/j.issn.1000-8578.2014.09.014
Citation: YANG Zhijun, CHEN Yanli, LI Li, YAO Desheng, ZHANG Jieqing. Impact of Different Treatment Models on Prognosis and QOL of Patients with Stage ⅡB Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(09): 1021-1025. DOI: 10.3971/j.issn.1000-8578.2014.09.014

不同治疗模式对ⅡB期宫颈癌患者预后和生活质量的影响

基金项目: 广西科学研究与技术开发计划课题资助项目(桂科攻1140003A-33)
详细信息
    作者简介:

    阳志军(1975-),男,博士,副主任医师,主要从事妇科肿瘤临床与基础研究

    通讯作者:

    李力,E-mail: lili@gxmu.edu.cn

  • 中图分类号: R737.33

Impact of Different Treatment Models on Prognosis and QOL of Patients with Stage ⅡB Cervical Cancer

  • 摘要: 目的 评价不同治疗方式对ⅡB期宫颈癌患者预后及生活质量的影响。方法 回顾性分析2000年01月01日至2010年12月31日,在广西医科大学附属肿瘤医院妇瘤科住院治疗的269例ⅡB期宫颈癌患者的病例资料,根据不同治疗方式分成4组。组1:单纯放射治疗组43例;组2:同步放化疗组98 例;组3:新辅助化疗或放化疗+手术组76例;组4:新辅助化疗或放化疗+手术+术后放疗和(或)化疗组52例,比较各组患者的5年生存率、5年无瘤生存率及生活质量,并分析影响预后的因素。结果 组2的预后最好,组4的预后最差;组2的预后优于组3,但差异无统计学意义;组1的预后优于组4,差异无统计学意义;组2、组3的预后优于组1、组4,差异有统计学意义。组1及组2的生活质量较差。结论 新辅助化疗或放化疗后加手术治疗尽管可改善部分ⅡB期宫颈癌的预后及生活质量,但仍需进一步开展前瞻性随机对照临床研究进一步证实。

     

    Abstract: Objective To evaluate the clinical effect of different treatment models on the prognosis and quality of life (QOL) of patients with stage ⅡB cervical cancer. Methods A total of 269 patients with stage ⅡB cervical cancer treated at Dept. of Gynecological Oncology of The Affiliated Tumor Hospital of Guangxi Medical University from January 1, 2000 to December 31, 2010 were retrospectively analysed and divided into 4 groups, Group 1: exclusive radiotherapy(43 cases), Group 2: concurrent chemoradiotherapy (96 cases), Group 3: neoadjuvant chemotherapy (NACT) or chemoradiotherapy plus radical hysterectomy and pelvic lymphadenectomy (76 cases), Group 4: Group3 followed adjuvant radiotherapy and/or chemotherapy(52 cases). The 5-year overall survival rate(OS), 5-year disease free survival rate(DFS) and QOL were compared and influence factors for survival were analyzed among 4 groups. Results Group 2 was with the best OS, however, Group 4 was with the worst OS. OS of Group 2 and 1 were better than those of Group 3 and 4 respectively, with no significant difference. OS of Group 2 and 3 were better than those of Group 1 and 4(P<0.05). QOL of both Group 1 and Group 2 were worse. Conclusion NACT or chemoradiotherapy plus surgery could improve OS, DFS and QOL of partial patients with stage ⅡB cervical cancer. More clinical trials are required to demonstrate the conclusion.

     

  • [1] Zhang XX, Wan CH, Lu YB,et al. Development and evaluation of quality of life instruments for cancer patients-cervix cancer (QLICP-CE)[J]. Zhongguo Zhong Liu,2009,18(3):183-6. [张晓馨, 万崇华,卢玉波,等.癌症患者生命质量测定量表体系之宫颈癌 量表QLICP-CE的研制及考评[J]. 中国肿瘤,2009,18(3):183-6.]
    [2] Greimel ER,Winter R,Kapp KS, et al.Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study [J].Psychooncology,2009,18(5):476-82.
    [3] Plotti F,Sansone M,Di Donato V,et al.Quality of life and sexual function after type C2/type Ⅲ radical hysterectomy for locally advanced cervical cancer:a prospective study[J].J Sex Med,2011,8(3): 894-904.
    [4] Han SS,Kim YH,Lee SH,et al.Underuse of ovarian transposition in reproductive-aged cancer patients treated by primary or adjuvant pelvic irradiation[J]. J Obstet Gynaecol Res, 2011,37(7):825-9.
    [5] Horn LC,Fischer U,Bilek K. Histopathological prognostic factors in primary surgically treated cervix carcinoma[J]. Zentralbl Gyna kol,2001,123(5):266-74.
    [6] Benedetti-Panici P,Greggi S,Colombo A,et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer:results from the Italian multicenter randomized study[J].J Clin Oncol,2002, 20 (1):179-88.
    [7] Yin M,Zhao F,Lou G,et al.The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer[J]. Int J Gynecol Cancer,2011, 21 (1):92-9.
    [8] Kaku S, Takahashi K, Murakami Y. Neoadjuvant intraarterial chemotherapy for stage ⅡB-ⅢB cervical cancer in Japanese women[J].Exp Ther Med,2010,1(4):651-5.
    [9] Feng SY,Zhang YN, Liu JG. Risk factors and prognosis of nodepositive cervical carcinoma[J].Ai Zheng,2005,24(10):1261-6.
    [10] Kodama J, Seki N, Masahiro S,et al. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy[J].J Surg Oncol,2010,101(5):413-7.
计量
  • 文章访问数:  1247
  • HTML全文浏览量:  323
  • PDF下载量:  805
  • 被引次数: 0
出版历程
  • 刊出日期:  2014-09-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭